产品名称 | NebuSelect™ Recombinant Human TRAIL Trimer, His-Flag-tag |
---|---|
目录号 | NBL-241993 |
别名 | Trail Trimer; Apo-2L; TRAIL; CD253; TNFSF10; Apo-2 ligand; APO2L; TL2 |
外观 | see COA |
分子量 | Gly118-Gly281 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P50591-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241993-100ug | 100ug | Inquire | Inquire | |
NBL-241993-1mg | 1mg | Inquire | Inquire | |
NBL-241993-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human TRAIL Trimer, His-Flag-tag
Catalog#:
NBL-241993
Description:
NebuSelect™ Recombinant Human TRAIL Trimer, His-Flag-tag(Cat#NBL-241993) is expressed in HEK293 with His tag and Flag tag at the N-Terminus.It contains Gly118-Gly281.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 60 kDa. Due to glycosylation, the protein migrates to 55-65 kDa based on Bis-Tris PAGE result.
Target Name:
Trail Trimer; Apo-2L; TRAIL; CD253; TNFSF10; Apo-2 ligand; APO2L; TL2
Target Information:
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily that can initiate the apoptosis pathway by binding to its associated death receptors DR4 and DR5. The activation of the TRAIL pathway in inducing tumor-selective apoptosis leads to the development of TRAIL-based cancer therapies, which include recombinant forms of TRAIL, TRAIL receptor agonists, and other therapeutic agents.
Amino Acid Sequence:
Gly118-Gly281
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.